GLP1R and Ehlers-Danlos syndrome: This connection is considered one of the mechanisms through which GLP-1 analogs support the treatment of specific EDs including BED [50]. This study identified a correlation between the administration of GLP-1 analogs and increased dietary disinhibition in this context.